HOME >> BIOLOGY >> NEWS
Flexibility In Cutting Toxic Releases Yields Dividends

CHAMPAIGN, Ill. - Changes in federal regulation giving chemical companies flexibility in deciding how to reduce toxic pollution are producing measurable results, according to researchers at the University of Illinois.

Economists Madhu Khanna and Lisa Damon studied the impact of the 33/50 program started by the Environmental Protection Agency (EPA) in 1991 to encourage firms to reduce their pollution emissions ­ by 33 percent by 1992 and by 50 percent by 1995. The voluntary program gave companies flexibility to determine how to reduce 17 highly toxic chemicals.

The EPA has since hailed the program as a success based on pollution reductions of 46 percent compared with the level shown in the 1988 Toxic Release Inventory.

In their independent sampling of chemical companies, Khanna and Damon found that the EPA's results were inflated by including pollution reductions that took place between 1988 and 1991 before the voluntary program began.

Nevertheless, sampled participants did reduce their overall releases by 41 percent between 1991 and 1993, and had a significantly better record in pollution reduction than chemical companies not participating in the program. The figures were adjusted to equalize size and other variables between participating and non-participating companies.

Their findings suggest that the new environmental initiatives "have been effective in motivating corporations to undertake self-regulated efforts to improve their environmental performance," Khanna and Damon concluded in a paper published by the U. of I. Program in Environmental and Resource Economics.

Moreover, the 33/50 program led to a positive change in the composition of wastes. "Firms have reduced their on-site releases and increased off-site transfers for recycling, energy recovery and treatment. This change is likely to lower the net risks associated with toxic waste generation."

Looking at the question of costs, the researchers found
'"/>

Contact: Mark Reutter
mreutter@uiuc.edu
(217) 333-0568
University of Illinois at Urbana-Champaign
4-Sep-1998


Page: 1 2

Related biology news :

1. Cutting-edge cancer researchers sought for international recognition
2. Cutting back on cigarettes: when less is more
3. AChemS: Cutting edge research in taste, smell, & chemical irritation
4. Cutting edge
5. Cutting-edge research to be presented at ASCPT pharmacology conference
6. Cutting the risk of coronary disease - start before birth says UK doctor
7. Story Tips: Engineering Students Pursue Cutting-Edge Research
8. Brain Building May Depend On DNA Cutting And Pasting
9. Cutting The Time And Cost Of Developing New Cures: Lord Sainsbury Launches Worlds First Biomedical Accelerator Mass Spectrometer In York
10. Gene Shears In Cutting Edge Anti-Aids Trial
11. NIEHS/NTP Director Dr. Kenneth Olden receives Society of Toxicologys Public Communications Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Flexibility Cutting Toxic Releases Yields Dividends

(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... CEO Conference on January 29 th at 10:30 ... CEO of NXT-ID will present and host a live ... wallet and its full suite of biometric technologies. Investors ...
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: ... market in general the State of Washington,s ... for a new enrollment and central issuance system for driver,s ... The project planning and development will start in ...
(Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
(Date:3/5/2015)... NORWALK, Conn. , March 5, 2015 /PRNewswire/ ... Network , a leading online community to ... understanding of the newest information available regarding the ... coverage of kidney cancer. March is ... there are very few effective adjuvant treatment options ...
(Date:3/5/2015)... March 5, 2015  In response to the incorrect ... Miami, FL on February 12, 2015. Impeto ... strong financial health and their SUDOSCAN® devices have been ... indicated. Furthermore, Impeto prefers to have the courts decide this ... more than 40 articles written by Key Opinion Leaders, ...
(Date:3/5/2015)... 05, 2015 The next implants made ... the CE mark (European) approval. The CE mark is ... Association (EFTA) and the European Union. Following the Class ... granted to implants supplied by the Turkey-based company Osimplant ... , Osimplant's Cervical Expandable Bladed HA PEEK Cage line ...
(Date:3/4/2015)... INCLINE VILLAGE, Nev. , March 4, 2015 PDL ... that the adjusted conversion rate for the: , ... Notes), is 174.8506 shares of common stock per $1,000 principal ... The conversion rate for the note is adjusted ... be paid on March 12, 2015, to all stockholders who own ...
Breaking Biology Technology:OncoTherapy Network Highlights Kidney Cancer Awareness Month 2OncoTherapy Network Highlights Kidney Cancer Awareness Month 3Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2
Cached News: